The study provides a detailed analysis of the industry, including the global respiratory care devices market share, size, trends, and growth forecasts.

IMARC Group, a leading market research company, has recently releases report titled “Respiratory Care Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global respiratory care devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How Big is the Respiratory Care Devices Market?  

The global respiratory care devices market size reached US$ 20.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.35% during 2023-2028.

Request For a Free PDF Sample Report:

What are Respiratory Care Devices?

Respiratory care devices refer to medical equipment used to assist patients with breathing difficulties or respiratory disorders. These devices include oxygen concentrators, nebulizers, ventilators, CPAP machines, and others. Respiratory care devices are designed to help patients breathe more easily, improve oxygen intake, and manage respiratory symptoms. They are used in various settings, including hospitals, clinics, and homes, and are crucial for treating respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and pneumonia. Respiratory care devices are usually prescribed by healthcare professionals and are available in a range of sizes and configurations to meet the individual needs of patients.

What are the Growth Prospects and Trends in the Respiratory Care Devices Market?

The increasing prevalence of respiratory disorders, including asthma, COPD, and sleep apnea, represents a key factor driving the market growth across the globe. This, coupled with the rising aging population is acting as a major growth-inducing factor. In line with this, the technological advancements in the development of respiratory devices, along with manufacturers focusing significantly on improving the efficiency, safety, and comfort of respiratory care devices are contributing to the growth of the market. The market is also driven by the increasing awareness regarding the benefits of effective utilization respiratory care devices. In addition to this, the rising demand for home healthcare solutions is creating a positive outlook for the market.

Buy this Report Now:

Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.

Who are the Key Players Operating in the Respiratory Care Devices Industry?

The report has also analyzed the competitive landscape of the market with some of the key players.

  • Philips Healthcare
  • ResMed
  • Chart Industries Inc.
  • Hamilton Medical
  • Medtronic, Masimo
  • Drägerwerk
  • Invacare Corporation
  • Allied Healthcare Products Inc
  • 3B Medical Inc.
  • Air Liquide
  • Fisher & Paykel Healthcare
  • GE Healthcare
  • Vyaire Medical Inc.
  • Rotech Healthcare Inc.

What is Included in Market Segmentation?

The report has categorized the market based on product, indication, end-user and region.

Breakup by Product:

  • Therapeutic Devices                 
  • Positive Airway Pressure (PAP) Devices        
  • Ventilators  
  • Nebulizers   
  • Humidifiers 
  • Inhalers      
  • Other
  • Monitoring Devices         
  • Pulse Oximeters             
  • Gas Analyzers
  • Others                   
  • Diagnostic Devices         
  • Spirometers
  • Polysomnography Devices        
  • Peak Flow Meters  
  • Others
  • Consumables and Accessories            
  • Masks        
  • Disposable Resuscitators
  • Breathing Circuits
  • Tracheostomy Tubes      
  • Nasal Cannulas
  • Others

Breakup by Indication:

  • Chronic Obstructive Pulmonary Disease (COPD)              
  • Asthma               
  • Sleep Apnea                  
  • Infectious Disease         
  • Others

Breakup by End-User

  • Hospitals     
  • Home Care Settings
  • Ambulatory Care Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Ask Analyst for Customization and Explore full report with TOC & List of

Key Highlights of The Report:                                                    

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal


Source link